IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, plans to announce first-quarter 2008 financial results before the market opens on Thursday, April 17, 2008. Executive management will review the company’s performance during a conference call with analysts at 8:00 a.m. ET on April 17.
| Participants may access the call via the following telephone numbers: | ||
| 1 800 926-5230 (U.S. and Canada) | ||
| 1 212 231-2906 (International) | ||
| A replay will be available beginning at 10:00 a.m. ET on April 17 until 10:00 a.m. ET on April 24 by dialing: | ||
| 1 800 633-8284 (U.S. and Canada) | ||
| 1 402 977-9140 (International) | ||
| Reservation number to access playback: 21380277 | ||
To listen to a live Webcast of the conference call, go to http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=67124& eventID=1814942. A replay of the presentation will be available at the site for seven days following the call.
(Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)
A copy of IMS’s earnings news release, and any other financial and statistical information presented during the analyst conference call, will be made available in the “Investors” area of IMS’s website at http://www.imshealth.com.
Operating in more than 100 countries, IMS Health is the world's leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.2 billion in 2007 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients' day-to-day operations, including portfolio optimization capabilities; launch and brand management solutions; sales force effectiveness innovations; managed care and over-the-counter offerings; and consulting and services solutions that improve ROI and the delivery of quality healthcare worldwide. Additional information is available at http://www.imshealth.com.
Contacts:
Darcie Peck, Investor Relations
203-845-5237
dpeck@imshealth.com
